CPT code 86828: HLA antibodies, both HLA classes2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Qualitative solid-phase testing detects whether antibodies to HLA Class I and Class II are present, commonly for transplant evaluation and monitoring.
Medicare pays $64.19 for 86828 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$64.19
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 86828 covers
This laboratory test determines whether a patient has antibodies to both HLA Class I and Class II antigens. Histocompatibility laboratories commonly perform it during transplant evaluation and after transplantation, when clinicians assess antibody status relevant to donor compatibility and immune risk. Solid-phase methods may include bead or microsphere assays, ELISA, or flow cytometry. The result is qualitative: it reports presence or absence rather than a semiquantitative panel level.
Report 86828 for a qualitative assessment covering both HLA classes. It is distinct from codes for testing one class, semiquantitative results, HLA typing, or a donor-recipient crossmatch. Medicare pays this laboratory test through the CLFS, with one national amount applying across localities and no office-versus-facility difference. The 2026 national CLFS amount is $64.19, unchanged since 2020. The service is paid only from the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 86828
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 86828. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 86828 with status X (excluded by statute), so the test itself is paid only from the CLFS.
86828 on the lab fee schedule since 2020
86828 · CLFS 2026 Q4 (current)
$64.19
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
86828 compared with similar tests
- 86829HLA antibodiesClass I or II, qualitative$64.19
- 86828 covers qualitative antibody assessment of both Class I and Class II. 86829 is the related option for qualitative assessment of Class I or Class II.
- 86832HLA antibody panelClass I, high-definition qualitative$323.75
- 86832 is for high-definition qualitative HLA antibody assessment specific to Class I; 86828 covers both Class I and Class II.
- 86834HLA antibody panelClass I, semiquantitative$357.56
- 86834 reports a semiquantitative Class I antibody panel. Choose 86828 for a qualitative assessment covering both classes.
- 86825HLA crossmatchFirst serum sample or dilution$109.49
- 86825 describes a noncytotoxic HLA crossmatch, while 86828 assesses the patient's HLA antibody status.
86828 billing questions
Does 86828 cover both HLA classes?
Yes. It represents qualitative antibody assessment for both Class I and Class II HLA antigens.
When should 86828 be chosen over 86829?
Use 86828 when the qualitative assessment covers both classes. Code 86829 is the related qualitative option for Class I or Class II.
How does 86828 differ from HLA typing?
86828 detects antibodies to HLA antigens. HLA typing identifies a person's HLA characteristics rather than testing for antibodies.
Is this a qualitative or semiquantitative test?
86828 is qualitative and reports antibody presence or absence. Semiquantitative panel testing is represented by different codes.
How does Medicare pay for 86828?
Medicare pays it under the CLFS at one national amount across localities, without an office-versus-facility difference. The code is paid only from the CLFS.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 86828 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist